MitoQ Launches Hormonal Metabolic Control to Support Women's Metabolic Health During Midlife

Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer

Novo Nordisk's Ozempic® pill, the only FDA-approved oral peptide GLP-1 medication for adults with type 2 diabetes, soon to be available in the US

Alcresta Therapeutics Announces Preclinical Data Evaluating RELiZORBneo Cartridge Use in Neonatal Murine Model of Necrotizing Enterocolitis

Aflac opens new South Portland office to support Maine Paid Family and Medical Leave Program

During National Show Your Smile Month, Kevin Guest Urges Leaders to Lift Others Daily

Keenova Presents a New TERLIVAZ® (terlipressin) Clinical Analysis at Digestive Disease Week

Harris Teeter Offers GLP-1 Medications, Nutrition Support and Cost-Saving Options

COREWELL HEALTH EAST TEAMSTERS TO PRACTICE PICKET AT GROSSE POINTE CAMPUS

Viatris Announces Several Data Presentations on Investigational Low-Dose Estrogen Combined Hormonal Contraceptive Weekly Patch at the 2026 American College of Obstetricians and Gynecologists Annual Clinical & Scientific Meeting

N-Butanol Market worth $8.77 billion by 2031 - Exclusive Report by MarketsandMarkets™

PureHealth Reports Revenue of USD 2.0 Billion and Net Profit of USD 113 Million in Q1-2026

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

From Sick Care to Whole Health: 5 Forces Reshaping the Future of Healthcare

Restore Vision Announces First-in-Human Clinical Interim Results for RV-001, a GPCR-Based Optogenetic Gene Therapy

Kodiak Sciences to Present Pipeline Advances and KSI-101 Clinical Data, Including Results from a MESI Cohort in a Tertiary Care Uveitis Practice, at Upcoming Scientific Conferences

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc. - TBPH

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ORIC Pharmaceuticals, Inc.- ORIC

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical Corporation - DERM

TLX101-Px (Pixlumi®) MAA Accepted in Europe

Bethany Medical Expands Pain Management & Weight Loss Practice Specialties